tiprankstipranks
pc:avanz

Avanzanite Bioscience

Strawinskylaan 3051 Amsterdam, North Holland 1077 ZX, NL
https://www.avanzanite.com/
Avanzanite Bioscience is a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases. The company aims to solve Europe's rare-disease medicines access gap by integrating commercial excellence, scientific expertise, and deep functional capability across market access, pricing, and reimbursement.

Leadership & Board

Current Number of Employees93
Current LinkedIn Followers5,787

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$32M
Total Amount Raised$32M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$32M
Latest Funding Amount$32M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

Avanzanite Bioscience had 93 employees as of September 7, 2026. The number of employees increased by 3 (3.33%) week-over-week.
93Latest Employee Count
3(3.33%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Avanzanite Bioscience had 5,787 followers as of September 7, 2026. The number of followers increased by 46 (0.80%) week-over-week.
5,787Latest Followers Count
46(0.80%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 18, 2025
Series A
$32.00M

Investors

Investor Name
Funding Round
Series A

Similar Companies

A snapshot of private companies similar to Avanzanite Bioscience, helping you discover and navigate related company profiles.

Related News and Analysis